Concerto HealthAI, a SymphonyAI portfolio company, is a next generation Real World Evidence company that partners with the American Society of Clinical Oncology’s CancerLinQ initiative and healthcare providers across the U.S. Concerto HealthAI develops engineered Real-World Data products designed for specific use cases, including post approval studies leading to label modifications and market access initiatives and regulatory submissions. Concerto HealthAI’s engineered datasets are deployed in a clinical cloud environment, with AI metadata, AI Models and AI-enabled applications all aligned to generate “precision evidence” required for high priority use cases.